Updated On: 01 February, 2026 03:36 PM IST | New Delhi | mid-day online correspondent
Presenting the Budget in Parliament, Sitharaman said the initiative is aimed at creating a robust ecosystem for biopharma and biosimilars, strengthening domestic capabilities and boosting India’s global competitiveness in high-value pharmaceutical manufacturing

Nirmala Sitharaman. Pic/PTI
Finance Minister Nirmala Sitharaman on Sunday announced a major push to position India as a global biopharmaceutical hub, unveiling a Rs 10,000-crore outlay over five years under a new Bio Pharma Shakti programme in the Union Budget 2026.
Presenting the Budget in Parliament, Sitharaman said the initiative is aimed at creating a robust ecosystem for biopharma and biosimilars, strengthening domestic capabilities and boosting India’s global competitiveness in high-value pharmaceutical manufacturing. The programme is expected to support research, innovation, manufacturing scale-up and supply-chain development across the biopharma sector.